Literature DB >> 22851893

Occurrence and severity of bronchopulmonary dysplasia and respiratory distress syndrome after a preterm birth.

Jennifer S Landry1, Dick Menzies.   

Abstract

BACKGROUND: Despite notable advances in neonatal care, bronchopulmonary dysplasia (BPD) remains an important complication of preterm birth, frequently resulting in prolonged hospital stay and long-term morbidity.
METHODS: A historical cohort study of all preterm infants (gestational age younger than 37 weeks) admitted to the Montreal Children's Hospital (Montreal, Quebec) between January 1, 1980, and December 31, 1992, was conducted. Information collected included demographic data, maternal and perinatal history, and main neonatal outcomes. Independent risk factors associated with BPD were identified by univariate analysis using one-way ANOVA, t tests or Mantel-Haenszel χ(2) testing. Severity of disease was studied using an ordinal multinomial logistic regression model.
RESULTS: In total, 1192 preterm infants were admitted, of whom 551 developed respiratory distress syndrome and 322 developed BPD. For each additional week of prematurity, the risk of developing BPD increased by 54% (adjusted OR 1.54/week [95% CI 1.45 to 1.64]). For each point subtracted on the 1 min Apgar score, the risk of developing BPD was increased by 16% (OR 1.16 [95% CI 1.1 to 1.3]). BPD was also associated with the presence of patent ductus arteriosus (OR 3.5 [95% CI 2.1 to 6.0]), pneumothorax in the first 48 h (OR 9.4 [95% CI 3.6 to 24.8]) or neonatal pneumonia/sepsis in the neonatal period (OR 1.9 [95% CI 1.1 to 3.2]). Severity of BPD was associated with gestational age, 1 min Apgar score, very low birth weight and the presence of neonatal pneumonia/sepsis.
CONCLUSION: Factors associated with BPD following a preterm birth were the degree of prematurity, birth weight, Apgar score at 1 min, and the presence of patent ductus arteriosus, pneumothorax or neonatal pneumonia/sepsis.

Entities:  

Keywords:  Bronchopulmonary dysplasia; Infant; Newborn; Premature; Respiratory distress syndrome

Year:  2011        PMID: 22851893      PMCID: PMC3200385          DOI: 10.1093/pch/16.7.399

Source DB:  PubMed          Journal:  Paediatr Child Health        ISSN: 1205-7088            Impact factor:   2.253


  17 in total

1.  Impact of postnatal systemic corticosteroids on mortality and cerebral palsy in preterm infants: effect modification by risk for chronic lung disease.

Authors:  Lex W Doyle; Henry L Halliday; Richard A Ehrenkranz; Peter G Davis; John C Sinclair
Journal:  Pediatrics       Date:  2005-03       Impact factor: 7.124

2.  Prenatal predictors of chronic lung disease in very preterm infants.

Authors:  D J Henderson-Smart; J L Hutchinson; D A Donoghue; N J Evans; J M Simpson; I Wright
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2005-08-30       Impact factor: 5.747

3.  Validation of the National Institutes of Health consensus definition of bronchopulmonary dysplasia.

Authors:  Richard A Ehrenkranz; Michele C Walsh; Betty R Vohr; Alan H Jobe; Linda L Wright; Avroy A Fanaroff; Lisa A Wrage; Kenneth Poole
Journal:  Pediatrics       Date:  2005-12       Impact factor: 7.124

4.  Multivariate assessment of traditional risk factors for chronic lung disease in very low birth weight neonates. The Newborn Lung Project.

Authors:  M Palta; D Gabbert; M R Weinstein; M E Peters
Journal:  J Pediatr       Date:  1991-08       Impact factor: 4.406

5.  Early versus late identification of infants at high risk of developing moderate to severe bronchopulmonary dysplasia.

Authors:  H J Rozycki; L Narla
Journal:  Pediatr Pulmonol       Date:  1996-06

6.  Prediction of risk of bronchopulmonary dysplasia.

Authors:  A Cohen; H W Taeusch
Journal:  Am J Perinatol       Date:  1983-10       Impact factor: 1.862

7.  A review of goodness of fit statistics for use in the development of logistic regression models.

Authors:  S Lemeshow; D W Hosmer
Journal:  Am J Epidemiol       Date:  1982-01       Impact factor: 4.897

8.  Bronchopulmonary dysplasia prediction model for 7-day-old infants.

Authors:  Carlos A Bhering; Christieny C Mochdece; Maria E L Moreira; José R Rocco; Guilherme M Sant'Anna
Journal:  J Pediatr (Rio J)       Date:  2007-03-20       Impact factor: 2.197

9.  Bronchopulmonary dysplasia: incidence, risk factors and resource utilization in a population of South American very low birth weight infants.

Authors:  Jose L Tapia; Daniel Agost; Angelica Alegria; Jane Standen; Marisol Escobar; Carlos Grandi; Gabriel Musante; Jaime Zegarra; Alberto Estay; Rodrigo Ramírez
Journal:  J Pediatr (Rio J)       Date:  2006 Jan-Feb       Impact factor: 2.197

Review 10.  Necrotising enterocolitis.

Authors:  J de Louvois
Journal:  J Hosp Infect       Date:  1986-01       Impact factor: 3.926

View more
  14 in total

1.  Long-term impact of bronchopulmonary dysplasia on pulmonary function.

Authors:  Jennifer S Landry; Tiffany Chan; Larry Lands; Dick Menzies
Journal:  Can Respir J       Date:  2011 Sep-Oct       Impact factor: 2.409

2.  Health care utilization by preterm infants with respiratory complications in Quebec.

Authors:  Jennifer Sophie Landry; Dan Croitoru; Yulan Jin; Kevin Schwartzman; Andrea Benedetti; Dick Menzies
Journal:  Can Respir J       Date:  2012 Jul-Aug       Impact factor: 2.409

3.  Effects of a superoxide dismutase mimetic on biomarkers of lung angiogenesis and alveolarization during hyperoxia with intermittent hypoxia.

Authors:  Michael Chang; Fayez Bany-Mohammed; M Cristina Kenney; Kay D Beharry
Journal:  Am J Transl Res       Date:  2013-09-25       Impact factor: 4.060

4.  Bronchopulmonary dysplasia - trends over three decades.

Authors:  Zofia Zysman-Colman; Genevieve M Tremblay; Suhair Bandeali; Jennifer S Landry
Journal:  Paediatr Child Health       Date:  2013-02       Impact factor: 2.253

5.  Extreme hyperleucocytosis of the premature.

Authors:  Esther Jansen; Judith Emmen; Thilo Mohns; Albertine Donker
Journal:  BMJ Case Rep       Date:  2013-04-19

6.  Differences in Comorbidities and Clinical Burden of Severe Bronchopulmonary Dysplasia Based on Disease Severity.

Authors:  Hye-Rim Kim; Young Hwa Jung; Beyong Il Kim; So Young Kim; Chang Won Choi
Journal:  Front Pediatr       Date:  2021-07-02       Impact factor: 3.418

7.  N-Terminal Pro-B Type Natriuretic Peptide as a Marker of Bronchopulmonary Dysplasia or Death in Very Preterm Neonates: A Cohort Study.

Authors:  Anna Sellmer; Vibeke Elisabeth Hjortdal; Jesper Vandborg Bjerre; Michael Rahbek Schmidt; Patrick J McNamara; Bodil Hammer Bech; Tine Brink Henriksen
Journal:  PLoS One       Date:  2015-10-09       Impact factor: 3.240

Review 8.  Postnatal Infections and Immunology Affecting Chronic Lung Disease of Prematurity.

Authors:  Gloria S Pryhuber
Journal:  Clin Perinatol       Date:  2015-10-01       Impact factor: 3.430

9.  Expression profiling of genes regulated by sphingosine kinase1 signaling in a murine model of hyperoxia induced neonatal bronchopulmonary dysplasia.

Authors:  Viswanathan Natarajan; Alison W Ha; Yangbasai Dong; Narsa M Reddy; David L Ebenezer; Prasad Kanteti; Sekhar P Reddy; J Usha Raj; Zhengdeng Lei; Mark Maienschein-Cline; Zarema Arbieva; Anantha Harijith
Journal:  BMC Genomics       Date:  2017-08-29       Impact factor: 3.969

10.  Hyperoxia-induced S1P1 signaling reduced angiogenesis by suppression of TIE-2 leading to experimental bronchopulmonary dysplasia.

Authors:  Tara Sudhadevi; Anjum Jafri; Alison W Ha; Prathima Basa; Jaya M Thomas; Panfeng Fu; Kishore Wary; Dolly Mehta; Viswanathan Natarajan; Anantha Harijith
Journal:  Cell Biochem Biophys       Date:  2021-06-27       Impact factor: 2.989

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.